Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 391 posts found.

novo_flag

Novo Nordisk breaks ground on new $2 billion production facility in North Carolina

March 29, 2016
Manufacturing and Production, Research and Development $2 billion, Clayton, Novo, Novo Nordisk, building, diabetes, nordisk, north carolina, production facility

Novo Nordisk has begun work on a new $2 billion production facility in Clayton, North Carolina, which will produce active …

News
sunpharma

Sun Pharma agree deal to distribute AstraZeneca type-2 diabetes drug in India

March 24, 2016
Sales and Marketing AstraZeneca, India, Sun Pharma, diabetes, oxra, type 2, type-2

Sun Pharma has agreed a deal with AstraZeneca to promote and distribute their type-2 diabetes drug, dapagliflozin, in India. Marketed …

News

Cellnovo, Roche sign deal to integrate diabetes platforms

March 15, 2016
Manufacturing and Production, Sales and Marketing Cellnovo, Roche, diabetes

Cellnovo Group (Paris: CLNV) on Tuesday said it has signed a deal with Swiss drug major Roche (Euronext: ROG) to …

News
novo_nordisk

Novo says diabetes drug Xultophy cost-effective versus insulin intensification treatment

March 2, 2016
Sales and Marketing Novo Nordisk, Xultophy, diabetes

Novo Nordisk says findings show its Tresiba and Victoza combo Xultophy (insulin degludec/liraglutide: IDegLira), is cost-effective compared to insulin intensification …

News
Baxalta logo

Bayer and Baxalta in separate €1 billion-plus deals

January 5, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Ascensia diabetes care, Baxalta, Bayer, diabetes, panasonic, symphogen

Baxalta has signed a deal with Symphogen potentially worth as much as €1.4 billion, under which the companies will develop …

News
FDA sign

FDA approves Lilly/Boehringer Lantus biosimilar

December 17, 2015
Medical Communications, Sales and Marketing Basaglar, Boehringer Ingelheim, Eli Lilly, Lantus, Sanofi, abasaglar, biosimilar, diabetes, insulin, lilly

The FDA has approved Eli Lilly and Boehringer Ingelheim’s long-acting insulin Basaglar (insulin glargine injection – a biosimilar to rival Sanofi’s …

News
Novolog pen

Novo Nordisk files for new insulin approval

December 10, 2015
Manufacturing and Production, Research and Development, Sales and Marketing FDA, NDA, Novo Nordisk, NovoLog, diabetes, insulin aspart, new drug application

Novo Nordisk has submitted a New Drug Application (NDA) for faster-acting insulin aspart to the FDA. If successful, the Danish …

News
Lilly_labs_2

Lilly pulls plug on basal insulin Peglispro

December 8, 2015
Manufacturing and Production R&D, basal insulin peglispro, diabetes, lilly, peglispro, phase III failure

Lilly has decided to pull out of filing its diabetes drug basal insulin peglispro, after failing to convince regulators and …

News
Victoza

Novo Nordisk buys Xoma diabetes program and scores trial successes

December 2, 2015
Research and Development, Sales and Marketing Novo Nordisk, Ryzodeg, SGLT2 inhibitors, Victoza, Xoma, diabetes

Novo Nordisk has announced its purchase of a type 2 diabetes diabetes program in a deal with biotech firm Xoma …

News

Personalised care key to diabetes management, says NICE

December 2, 2015
Research and Development NICE, NICE guidelines, diabetes, type 2 diabetes

UK drugs regulator NICE has published updated guidelines on type 2 diabetes, saying that taking an individualised approach to care …

News
Diabetes treatments

Featured Market Report: Type 2 Diabetes – Epidemiology Forecast to 2024

November 16, 2015
Manufacturing and Production, Research and Development diabetes, market reports

Diabetes is one of the most common non-communicable diseases worldwide and is an escalating public health problem globally, with an …

Feature
Janssen image

Janssen buys licence to diabetes and obesity drugs from Hanmi

November 10, 2015
Manufacturing and Production, Research and Development Janssen, diabetes, hanmi

Janssen could spend up to a billion dollars to buy for novel clinical stage biologics to treat diabetes and obesity. …

News

Jardiance scores more cardiovascular outcomes data

November 10, 2015
Manufacturing and Production Boehringer, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Victoza, cardiovascular outcomes, diabetes, empagliflozin, jardiance, lilly, liraglutide, type 2 diabetes

A sub-group analysis of data from an outcomes study of Boehringer Ingelheim’s and Lilly’s Jardiance has found the diabetes drug …

News
Pascale Witz Sanofi

Sanofi and Hanmi partner to create long-acting diabetes treatments

November 5, 2015
Manufacturing and Production, Research and Development Korea, Sanofi, diabetes, hanmi

Sanofi and Hanmi Pharmaceutical have announced a worldwide license agreement to develop a portfolio of experimental, long-acting diabetes treatments. Korea’s …

News
MRI obese overweight

Novo Nordisk forms academic partnership with Washington Uni

November 4, 2015
Research and Development Novo Nordisk, diabetes, obesity

Novo Nordisk has launched a new research collaboration with researchers at the University of Washington, to develop new drugs for …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026